Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (A Viewpoint)
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
Confounding in association studies: month of birth and multiple sclerosis.
Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
Suppression of Murine Experimental Autoimmune Optic Neuritis by Mature Dendritic Cells Transfected with Calcitonin Gene-Related Peptide Gene.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
Pages
« first
‹ previous
…
141
142
143
144
145
146
147
148
149
…
next ›
last »